Speaker Profiles

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

Manon Auger, McGill University and McGill University Health Center

After obtaining her MD degree at McGill University, Dr. Auger completed her residency training in Anatomical Pathology at the University of Toronto, followed by a Cytopathology Fellowship at the University of Texas M.D. Anderson Cancer Center in Houston. She is Director of the Cytopathology Laboratory at the McGill University Health Center and is Professor in the Department of Pathology at McGill University. Her interests relate to all aspects of cytopathology, including FNA cytology of the thyroid.

Back to top

 

Christine Ayotte, INRS – Institut Armand-Frappier, Montreal

Christiane Ayotte holds a Ph.D. degree in organic chemistry from Université de Montréal. She is a professor at the Institut national de la recherche scientifique (INRS-Institut Armand-Frappier) and the Head of its Doping Control Laboratory, the only Canadian laboratory accredited by the World Anti-Doping Agency (WADA). She provides her scientific expertise to international sport organizations, is a member of WADA Laboratory Expert Group and of the Medical Commission of the International Olympic Committee (IOC) for Olympic Games held in Beijing, London and Sochi.

Her expertise is often required at hearings and arbitrations when the results of doping control tests are challenged. She participates to lectures and workshops to inform athletes, trainers, coaches, physicians, doping control officers; she particularly combats the use of medications and drugs outside the legitimate medical context for image and performance enhancing purposes.

The Doping Control Laboratory of the INRS is one of the three North American Laboratories accredited for anti-doping programs. The laboratory analyses approximately 25 000 blood and urine samples collected for the Canadian anti-doping program (partnership with CCES) and international sport organizations like the International Tennis Federation and the North American professional leagues such as the MLB, NBA, MLS and NHL. A satellite laboratory of the INRS was established under her direction in Richmond, BC for the Vancouver Olympic Games of 2010.

Back to top

 

Farhan Bhanji, McGill University, Royal College of Physicians and Surgeons of Canada

Farhan is a Pediatric Critical Care and Emergency Medicine Physician at the Montreal Children’s Hospital and served as the Residency Program Director for the Pediatric Emergency Medicine Program until 2013. He also serves as the Director of the Fellowship in Health Professions Education at McGill University and is the interprofessional lead for Simulation at the Montreal Children’s Hospital. Farhan is a CanMEDS Clinician Educator and the Associate Director of Assessment at the Royal College of Physicians of Canada – where he oversees the Assessment of Specialist Physicians in Canada. Most recently Farhan was a Visiting Professor at the Medical Education Development Center of Gifu University, Japan from January to March 2013.

Back to top

 

Güliz A. Barkan, Loyola University Medical Center

Güliz A. Barkan, M.D., FIAC is a board certified Anatomic Pathologist and Cytopathologist, Associate Professor of Pathology and Urology, and currently the Director of Cytology, the Director of the Residency Program in Anatomic and Clinical Pathology, the Director of the Cytopathology Fellowship Program and the vice chair of education at Loyola University Medical Center, Maywood, IL.

Dr. Barkan received her medical degree from Marmara University School of Medicine in Istanbul, Turkey in 1995. She completed residency in Anatomic and Clinical Pathology at The University of Michigan, Ann Arbor, Michigan in 2001. She finished a Surgical Pathology fellowship in the same institution in 2002 and a Cytopathology fellowship at the University of Texas M.D. Anderson Cancer Center, Houston, Texas in 2003. After a brief period in private practice in Turkey she joined Loyola University Department of Pathology in January 2006. Her interests include surgical pathology and cytopathology of the genitourinary tract, and pathology education. She has authored a number of peer reviewed publications, abstracts, chapters, and given national and international invited talks and workshops mostly in the fields of cytopathology and surgical pathology of the genitourinary system.

She is serving as a member of the American Board of Pathology Test Committee, and a member of the Pathology Residency Program Directors Council. Actively involved with the American Society of Cytopathology, she is a member of the Executive Board and current chair of the Cyto-e conference Committee. She is a fellow of the International Academy of Cytology.

Back to top

 

Richard BeliveauRichard Beliveau, Notre-Dame Hospital

Richard Béliveau, docteur en biochimie, est directeur du laboratoire de Médecine Moléculaire à l'Université du Québec à Montréal, où il est directeur scientifique de la Chaire en Prévention et Traitement du Cancer. Il a été professeur de chirurgie et de physiologie à la faculté de médecine de l'Université de Montréal et titulaire de la Chaire de Neurochirurgie du CHUM et également chercheur associé au Centre de Prévention du Cancer du département d'oncologie de l'Université McGill, membre du Groupe de Thérapie Expérimentale du Cancer de l'Hôpital général juif de Montréal, professeur titulaire de biochimie à l'UQAM et membre de la Coalition priorité cancer au Québec. Il est fondateur de l'entreprise Angiochem qui développe des nouvelles thérapies pour les maladies du cerveau. Auteur de plus de 240 publications dans des revues médicales à l'échelle internationale, il est auteur des best-sellers Les Aliments contre le cancer, Cuisiner avec les aliments contre le cancer, La Santé par le plaisir de bien manger et La Mort, et tout récemment, Prévenir le cancer, tous parus chez Trécarré, tous traduits en 27 langues et distribués dans 35 pays.

Il est lauréat du grand prix public du Salon du livre de Montréal, de la Personnalité de l'année du magazine L'Actualité et Personnalité du Québec du magazine Au Québec. Il a été nommé Ancien Émérite de l'Université Laval, de l'Université du Québec, du collège de Trois-Rivières et du Séminaire St-Joseph.

Back to top

 

Miriam Blumenkrantz, Montreal Children’s Hospital

After Pathology residency and fellowship in Cytogenetics at McGill University, Dr. Blumenkrantz completed a fellowship in Pediatric Pathology at Columbus Children’s Hospital in 2003. She obtained her certification in Cytogenetics by the Canadian College of Medical Geneticists in 2004 and joined the Department of Pathology at the Montreal Children’s Hospital in the same year. She currently serves as the Pathology Department’s Director of Quality Assurance and is an Associate Director of Cytogenetics.

Back to top

 

Jonathan ClaussenJonathan Claussen, Iowa State University

Prof. Jonathan Claussen obtained his BS and BA in Mechanical Engineering and Spanish/Portuguese studies respectively at the University of Minnesota – Twin Cities. At Purdue University he received his MS and PhD in Mechanical and Biological Engineering respectively while researching carbon nanomaterial (graphene and carbon nanotube) based electrochemical biosensors. Jonathan next worked as a postdoctoral scholar at the University of California San Diego developing nano/ microrockets and microneedle arrays for drug delievery and biosensing. After his postdoc experience, he worked at the Center for BioMolecular Science and Engineering at US Naval Research Laboratory as an Assistant Research Professor at George Mason University. During this time he worked on optical based sensors/biosensors with quantum dots. Jonathan currently is an Assistant Professor at Iowa State University. His research laboratory is focused on understanding/developing science and technology that interfaces with biology on the nano/microscale. His research interests are focused on developing point-of-care or on-site biosensors for disease diagnostics, environmental monitoring, forensic analysis, and food safety.

Back to top

 

Jacques CoteJacques Côté

Jacques Côté lives in Quebec City and teaches at Cégep de Sainte-Foy. In 2000, he published his first crime novel : Nébulosité croissante en fin de journée, followed by Le Rouge idéal (2002), the second part of the series, for which he received the 2003 Arthur Ellis Award for best crime novel in Canada. He also won this award in 2009 for Le Chemin des brumes and for Dans le Quartier des agités in 2011.

As a forensic historian, Côté wrote Wilfrid Derome, expert en homicides (2003). Winner of the Grand Prix La Presse for best biography, a book that increased public awareness of this North American pioneer in law and forensic medicine. Jacques Côté has been a guest lecturer at L'École de criminologie de Montréal, at the Laboratoire de sciences judiciaires et de médecine légale, and also at the Annual Conference of Chief Coroners and Chief Medical Examiners of Canada. In 2004, he worked on a documentary about the life of Wilfrid Derome for the cable network Canal D. In 2014, «Le comité du centième anniversaire du Laboratoire de sciences judiciaires et de médecine légale de Montréal » mandated Côté to write a book to commemorate the 100th anniversary of the lab. It will be release in october 2015 by Les Publication du Québec.

Back to top

 

Bojana DjordjevicBojana Djordjevic

Dr. Bojana Djordjevic is a gynecologic pathologist at The Ottawa Hospital and an assistant professor at the University of Ottawa. She received her Bachelor’s of Science degree in Biochemistry from the McGill University, her MD degree from the University of Alberta, and her anatomical pathology residency training at the University of Toronto. She holds fellowships in gynecologic pathology and cancer biomarkers from the M.D. Anderson Cancer Center.

Dr. Djordjevic is appointed at The Ottawa Health Research Institute as a clinical investigator. The primary focus of her research work has been the discovery of prognostic and predictive markers in endometrial carcinoma, as well as their validation and adaptation for clinical use. Dr. Djordjevic is the author of several publications in the American Journal of Pathology and Modern Pathology, four book chapters and numerous abstracts. She received the Jesse H. Jones Fellowship Award from the M.D. Anderson Cancer Center in 2010 and is the 2013 recipient of the Stephen F. Vogel Award from the United States and Canadian Academy of Pathology.

Back to top

 

Jennifer M. Dmetrichuk, McMaster University

Dr. Jennifer M. Dmetrichuk is a second year General Pathology resident at McMaster University. Jennifer earned her Honours BSc with First Class Standing and PhD with Distinction in Biological Sciences from Brock University, Canada. Jennifer continued her training in the UK, where she received her MBChB with Distinction from the University of Aberdeen, Scotland, having carried out her research elective at Johns Hopkins Hospital, USA. She continued her training at University College London, England as an Academic Foundation Programme Doctor. Jennifer has returned to Canada to pursue her interests in Oncology and Pathology.

Back to top

 

Marie-Pierre Dubé, Montreal Heart Institute, Université de Montréal

Marie-Pierre Dubé is Associate Professor in the Department of Medicine at the Université de Montréal. She is the director of the Beaulieu-Saucier Pharmacogenomics Centre at the Montreal Heart Institute where she leads clinical research projects in pharmacogenomics and personalized medicine. Dr. Dubé completed a PhD in genetics at McGill University and post-doctoral studies in public health at University of Toronto. She worked at Xenon Pharmaceuticals before taking her current academic position. Dr Dubé has authored over 100 articles in peer-reviewed journals and 11 patents. She is a member of the editorial board of Circulation Cardiovascular Genetics and academic editor at PLoS One. She received two career awards from the FRSQ, the Champions in Genetics award from the Canadian Gene Cure Foundation, and her research is funded by the CIHR, Genome Quebec and Genome Canada. She has been involved in several pharmacogenomic studies of phase 3 clinical trials including ILLUMINATE, dal-OUTCOMES and SIGNIFY. She is the principal investigator of a large prospective pharmacogenomics study on anticoagulation therapy as well as a personalized medicine study of statin induced myotoxicity.

Back to top

 

Lyn McDivitt DuncanLyn McDivitt Duncan, Harvard Medical School, Massachusetts General Hospital Dermatopathology Service

Lyn McDivitt Duncan, M.D. trained in Anatomic Pathology at Washington University in St. Louis and in Dermatopathology at the Massachusetts General Hospital and Harvard Medical School. She is the Chief of the MGH Dermatopathology Unit and Professor of Pathology at Harvard Medical School. As a leader in diagnostic and consultative dermatopathology Dr. Duncan has a special expertise in melanoma and cutaneous lymphoma. She has written over 100 published articles and 30 book chapters, including revised classifications of cutaneous B-cell lymphoma, descriptions of benign mimics of melanoma including nevoid melanoma, atypical Spitz tumors and combined nevi, and the development of optimal analytical platforms and management algorithms for sentinel lymph nodes. In addition to chapters in the WHO Classification of Skin Tumours (2006) & the WHO Classification of Tumours of Hematopoetic and Lymphoid Tissues (2009) she is the author of the Atlas of Essential Dermatopathology (Springer 2013) and the Atlas of Cutaneous Lymphoma (Springer-Verlag 2015). Dr. Duncan serves on the editorial board of the Journal of Cutaneous Pathology and is a member of the International Melanoma Study Group and the United States Cutaneous Lymphoma Consortium.

Back to top

 

Ronan Foley, Juravinski Cancer Centre, McMaster University

Ronan Foley, MD, FRCPC, is a clinical hematologist with an active practice in malignant hematology at the Juravinski Cancer Centre. He is Director of the Stem Cell Laboratory and Cell Diagnostic Units. Dr. Foley is an Associate Professor of Pathology and Molecular Medicine at McMaster University, Past-President of CBMTG, a Director of the Clinical Trials Network and a member of the NIH Consensus Panel for the Diagnosis and Classification of Chronic Graft vs. Host Disease along with several other affiliations. Other activities include board membership on OCREB and panel chair for the CIHR CBT panel. Dr. Foley’s current research focus is the development of therapeutic cell-based autologous vaccines. He has held grants with CANVAC, OICR, CIHR, OCRN, and CBCRA. As P.I. he has extensive experience in coordinating multi-disciplinary, translational programs, bringing together several teams and securing funding. He currently collaborates with The Stem Cell Institute and OCOG to study the effects of thioridazine on leukemia stem cells. He has many years of experience as an educator in the undergraduate MD program, post-graduate residency training programmes and the graduate studies program.

Back to top

 

Michael Geraghty, Childrens Hospital Eastern Ontario, University of Ottawa

Dr. Geraghty is Head of Metabolics and Professor of Pediatrics at Children’s Hospital Eastern Ontario and the University of Ottawa. He obtained his medical degree at University College Dublin, Ireland and a MSc in Medical Genetics at Trinity College, Dublin. He was a Howard Hughes Medical Institute Fellow in Medical Genetics at the Johns Hopkins University School of Hospital from 1988-92. He remained on Faculty at JHU and was Clinical Director of the Institute of Genetic Medicine until 2002.

Dr. Geraghty moved to Ottawa in 2002 and established the Metabolics program. He was the co- principal in establishing the expanded Ontario Newborn Screening Program in Ottawa in 2006. Currently he is a Medical Consultant to Newborn Screening Ontario. He is a member of the Advisory Board to Newborn Screening Ontario, a member of the Maternal Child Screening Committee in Ontario and Chair of the Metabolics committee in the Canadian College of Medical Genetics.

Back to top

 

Marcio Mendes Gomes, University of Ottawa, The Ottawa Hospital

Dr. Marcio Gomes is an Associate Professor in the Department of Pathology and Laboratory Medicine at the University of Ottawa, and a staff pathologist, thoracic pathology lead, at The Ottawa Hospital. He obtained his medical degree (1995), residency training (1999) and PhD (2003) at the University of Sao Paulo, Brazil. After 3 years at the Université de Sherbrooke, he moved to the University of Ottawa in 2008. Dr. Gomes is a medical teacher and educator and his main areas of interest are thoracic pathology and interprofessional education. In 2009, he created the Interdisciplinary Thoracic Pathology Meetings, which was the main initiative behind the 2010 Award of Excellence and Innovation in Postgraduate Medical Education by the University of Ottawa. He is a Distinguished Teacher of the University of Ottawa, was the 2014 recipient of the Professional Association of Residents of Ontario (PARO) Clinical Teaching Award for the University of Ottawa, and recently became a member of the Royal College International Academy of Educators.

Back to top

 

David GrynspanDavid Grynspan, CHEO, University of Ottawa

David Grynspan is a pediatric Pathologist at CHEO and University of Ottawa. He completed Medicine at U of T (2000), a pathology residency at UBC (2006) and a Fellowship in Pediatric Pathology at Wayne State, Detroit (2007). David is on the Residency program Committee of University of Ottawa, Pathology and the Fellowship Committee for Maternal and Fetal Medicine. Research interests include placenta pathology and enteric neuroscience. David is the site coordinator for pathology education at CHEO.

Back to top

 

Pauline HenryPauline Henry, Toronto East General Hospital, University of Toronto

Dr. Pauline Henry completed an Honours Bachelor of Science degree in Molecular Biology and Biotechnology at McMaster University and then an MD/PhD degree at the University of Toronto (U of T). Her research interests during graduate studies focused on the specificity of protein-protein interactions within the ubiquitin ligase cellular protein degradation pathway. She continued at U of T to obtain postgraduate Residency training in Anatomic Pathology followed by a Gastrointestinal/Hepatobiliary Pathology Fellowship. She is currently a staff pathologist at Toronto East General Hospital and an Assistant Professor in the U of T Department of Laboratory Medicine and Pathobiology where she is actively involved in Residency Training including development and implementation of Resident evaluation tools and programs.

Back to top

 

J. Conor O’KeaneJayantha Herath, Ontario Forensic Pathology Service, University of Toronto

Dr. Jayantha Herath is a Staff Forensic Pathologist and the Medical Director of the Provincial Forensic Pathology Unit (Toronto) of the Ontario Forensic Pathology Service. He is also an Investigative Coroner (FP-C) for homicides and criminally suspicious deaths in Ontario. He is an Assistant Professor of Department of Pathobiology of University of Toronto. He obtained his medical degree (MD) and master’s degree (MSc) from the Medical University of Varna, Bulgaria (1993). He obtained post-graduate Diploma in Legal Medicine (DLM 1999) and Doctor of Forensic Medicine (MD, Forensic 2002) from University of Colombo, Sri Lanka. He completed his residency in Anatomical Pathology (2010) and Fellowship in Forensic Pathology at the University of Manitoba, Canada. He obtained Specialist Certification in Anatomical Pathology (2010) and sub-specialty Certification in Forensic Pathology (2012) from the Royal College of Canada (FRCPC).

Back to top

 

Frances Jamieson, Mount Sinai Hospital, University of Toronto, Public Health Ontario

Dr. Jamieson obtained her MD from the University of Toronto in 1984. She trained in anatomic pathology and medical microbiology at the University of Toronto, and received her Fellowship from the Royal College of Physicians and Surgeons in Medical Microbiology in 1991. Dr. Jamieson was a Federal Field Epidemiologist and Staff Medical Microbiologist at the Hospital for Sick Children prior to joining the Public Health Laboratories (now part of Public Health Ontario) in 1996, where Dr. Jamieson was the Associate Medical Director and Medical Director (Acting) from 2010 – 2013. Dr. Jamieson is responsible for the tuberculosis and mycobacteriology laboratory as well as bacterial vaccine-preventable diseases, laboratory surveillance and data management, and emergency response. She holds an appointment as Associate Professor and Graduate Faculty, Dept. of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, and as assistant scientific staff, Dept of Microbiology, Mount Sinai Hospital.

Dr. Jamieson has managed and led the public health laboratory response for several large outbreaks, including Walkerton and SARS. She received the Ontario Ministry of Health and Long-Term Care ACE award for outstanding achievement in 2001, 2002, 2004, and 2005 and was nominated for the John G. Fitzgerald Outstanding Microbiologist Award in 2013. She received the National LEADing Practice award from Canada Health Infoway and Accreditation Canada in 2014 for her conception and development of the Ontario Universal Typing-Tuberculosis application (OUT-TB Web), an on-line platform for enhanced TB surveillance that provides near-time comprehensive genotype and epidemiological data in an actionable, user-friendly and usable format for the end-user.

Dr. Jamieson has over 150 peer-reviewed publications, and has served on a large number of international, national, provincial and Public Health Ontario committees. She currently serves as the provincial co-chair for the Canadian Public Health Laboratory Network.

Back to top

 

Jeffrey T. Joseph, University of Calgary

Dr. Joseph is a general neuropathologist and section head of neuropathology at Foothills Medical Centre in Calgary. His work involves all aspects of neuropathology, including foetal and perinatal, pediatric, neoplastic, neurodegenerative and dementia, forensic, and neuromuscular neuropathology. He is also establishing a dementia and neurodegenerative disease brain bank in Calgary.

Dr. Joseph graduated from Harvard Medical School, trained in pathology and neuropathology at the Brigham and Women’s Hospital in Boston, and practiced neuropathology for 12 years at the Beth Israel Deaconess Medical Center in Boston prior to starting neuropathology work in 2007 in Calgary.

Back to top

 

David L. KatzDavid L. Katz, Yale University School of Medicine

David L. Katz, MD, MPH, FACPM, FACP earned his BA degree from Dartmouth College (1984; in 3 years); his MD from the Albert Einstein College of Medicine (1988); and his MPH from the Yale University School of Public Health (1993). He completed sequential residency training in Internal Medicine (Norwalk Hospital, CT; 1991), and Preventive Medicine/Public Health (Yale University School of Medicine; 1993). He is a two-time diplomate of the American Board of Internal Medicine, and a board-certified specialist in Preventive Medicine/Public Health. He received an Honorary Doctorate (Humane Letters; L.H.D.) from the University of Bridgeport in 2013; and will receive a second honorary doctorate in 2015.

Dr. Katz is the founding director (1998) of Yale University’s Yale-Griffin Prevention Research Center; President of the American College of Lifestyle Medicine; Editor-in-Chief of the journal, Childhood Obesity; Chief Science Officer for NuVal LLC; and founding director (2000) of the Integrative Medicine Center at Griffin Hospital. He is on numerous editorial and scientific advisory boards, chairing several. A clinician, researcher, author, novelist, inventor, poet, journalist, and media personality, Dr. Katz is the recipient of numerous awards and recognitions. He has been a widely supported nominee for the position of U.S. Surgeon General, and has been recognized by Greatist.com as one of the 100 most influential people in health and fitness in the world for the past 3 years (2013-). Dr. Katz was among the original 150 thought leaders invited by LinkedIN to blog as an INfluencer, and currently ranks in the top 40 on a list that includes the President of the United States; the Prime Minister of England; the Prime Minister of India; the Secretary General of the United Nations; the President of the World Bank; Bill Gates; Richard Branson; Arianna Huffington, among many other notables. He has appeared on most major television news programs and talk shows in the U.S., and is a frequent guest on National Public Radio programs around the country. He is a frequent source for print journalists around the world. He has a social media following of approximately 500,000.

Dr. Katz holds 5 U.S. patents. He has authored over 200 scientific papers and chapters, 15 books, and well over 1,000 columns and blogs.

Dr. Katz is recognized globally for expertise in nutrition, weight management and the prevention of chronic disease. He has delivered addresses in numerous countries on four continents, and has been acclaimed by colleagues as the “poet laureate” of health promotion.

Dr. Katz and his wife, Catherine S. Katz, PhD (founder of www.cuisinicity.com) live in Connecticut. They have 5 children.

Back to top

 

Julia KeithJulia Keith, Sunnybrook Health Sciences Centre, University of Toronto

Dr. Julia Keith is the Neuropathologist and Deputy Chief of Anatomical Pathology at Sunnybrook Health Sciences Centre, and she provides diagnostic support for the Sunnybrook Brain Sciences Program, including the CNS site group of the Odette Cancer Centre and the Cognitive Neurology and Neuromuscular programs. Her academic interests include Education, and she is an Assistant Professor and the Residency Program Director in Neuropathology at the University of Toronto.

Back to top

 

Sébastien LabontéSébastien Labonté, CHU-L’Hôtel-Dieu de Québec

Dr. Labonte obtained his MD from University of Sherbrooke, and trained in Anatomic Pathology at Laval University, where he graduated in 2001. He then went to Memorial Sloan-Kettering Cancer Center for an oncologic surgical pathology fellowship in 2001-2002, and came back to work as an attending pathologist at l’hôpital de l’Enfant-Jésus in Quebec city. He left for Toronto in 2005-2006 to train in dermatopathology, and subsequently joined the pathology team at L’Hôtel-Dieu de Québec, where he still works. His practice is dedicated to bone / soft tissue tumors and dermatopathology. Academically, Dr. Labonte is involved in teaching to medical students and residents, and has been a speaker at multiple conferences. He is currently associate editor for the journal Annales de Pathologie. In 2011 he was appointed associate clinical professor at Laval University Faculty of Medicine.

Back to top

 

Nathan Ledeboer, Medical College of Wisconsin

Nathan A. Ledeboer, Ph.D., D(ABMM) received his B.A. Degree in 2000 and his Ph.D. Degree in Microbiology from the University of Iowa in 2005. Following two years of fellowship training in clinical and public health microbiology at Washington University School of Medicine in Saint Louis, MO, he joined the faculty of the Department of Pathology at the Medical College of Wisconsin in Milwaukee, WI. He is currently an Associate Professor and Medical Director of Microbiology, Molecular Diagnostics, reference services, and laboratory business development at Froedtert Hospital and Dynacare Laboratories in Milwaukee, WI. His research endeavors, particularly in the area developing diagnostic tools for infectious diseases, have led to numerous publications in peer-reviewed journals and more than 100 funded research projects. Dr. Ledeboer is also a senior editor for the Journal of Clinical Microbiology.

Back to top

 

Alice Lytwyn, McMaster University

Dr. Lytwyn is an associate professor in the Department of Pathology and Molecular Medicine and an associate member of the Department of Clinical Epidemilogy and Biostatistics at McMaster University.

Back to top

 

Kathleen A. McMonigalKathleen A. McMonigal, NASA/Johnson Space Center

Kathleen A. McMonigal, MD, FCAP, is the Director of Clinical Laboratories for the National Aeronautics and Space Administration (NASA) at the Lyndon B. Johnson Space Center in Houston, Texas. Dr. McMonigal oversees astronaut and occupational medicine laboratory testing at NASA. She is past chair of NASA’s Institutional Review Board. Her clinical laboratory team supports operational and research activities in the NASA space flight program. Dr. McMonigal earned her medical degree from the University of Minnesota in Minneapolis. She completed a residency in anatomical and clinical pathology and a fellowship in virology and microbiology, also at the University of Minnesota.

Back to top

 

L. Jeffrey Medeiros, The University of Texas, MD Anderson Cancer Center

Dr. Medeiros received his MD from the University of Massachusetts and did residency in Anatomic and Clinical Pathology at the New England Deaconess Hospital in Boston (now Beth Israel Deaconess Medical Center). He also completed four years of fellowship training: two years at Stanford University Medical Center (Surgical Pathology and Immunopathology), one year at Massachusetts General Hospital (Hematopathology), and one year at the National Cancer Institute (Hematopathology). His first job was a junior staff position at the National Cancer Institute. His first senior staff position was an Associate Professor of Pathology at Rhode Island Hospital/Brown University of School of Medicine, in Providence, Rhode Island. He subsequently was appointed Director of Hematopathology at City of Hope National Medical Center, in Duarte, California. In 1998, he joined the faculty at The University of Texas MD Anderson Cancer Center and he became the first Chair of the newly created Department of Hematopathology in 2002.

Dr. Medeiros is a member of the editorial boards of a number of journals including the American Journal of Clinical Pathology, American Journal of Surgical Pathology, Human Pathology, and Modern Pathology. He is co-author of three books: Ioachim’s Lymph Node Pathology (Lippincott Williams & Wilkins, 2007), Diagnostic Pathology: Lymph Nodes and Spleen with Extranodal Lymphomas (AMIRSYS, 2011), and Atlas of Lymph Node Pathology (Springer, 2013). Dr. Medeiros also has written a number of peer review publications. His interests include the diagnosis of lymphomas, including the use of histologic, immunophenotypic and molecular methods for diagnosis and prognosis, and he his recent research interests have focused on diffuse aggressive B-cell lymphomas.

Back to top

 

Christopher Milroy, Eastern Ontario Forensic Pathology Unit, University of Ottawa

Dr. Christopher Milroy is the Director of the Eastern Ontario Forensic Pathology Unit based in Ottawa and a Full Professor in the University of Ottawa. He qualified in Medicine from the University of Liverpool in Medicine and has a Bachelor of Laws and a Master of Laws from the University of London. He is a Fellow of the Royal College of Pathologists and the Royal College of Physicians of Canada. He was a Forensic Pathologist at the University of Sheffield from 1990-2008. Since 2008 he has been based in Ottawa. He has published over 100 articles and chapters on Forensic and Anatomical Pathology.

He worked for the International Criminal Tribunal for the Former Yugoslavia (ICTY) and has prepared reports for Human Rights groups and has given written evidence in cases before the European Court of Human Rights. He acted as an expert for the ICRCs report “The MIssing”.

Dr. Christopher Milroy is a qualified Anatomical and Forensic Pathologist who is the Director of the Eastern Ontario Forensic Pathology Unit based in Ottawa and a Full Professor at the University of Ottawa. He qualified in medicine from the University of Liverpool and has law degrees (LLB, LLM) from the University of London. He is a Fellow of the Royal College of Pathologists and the Royal College of Physicians of Canada, where he currently Chairs the Forensic Pathology Examiners’ committee. He worked as a Forensic Pathologist at the University of Sheffield, UK from 1990-2008. Since 2008 he has been based in Ottawa.

He is the Associate Editor of the Journal of Forensic and Legal Medicine and has published over 100 articles and chapters on Forensic and Anatomical Pathology and has a special interest in the Pathology and Toxicology of drugs of abuse.

Back to top

 

Adam NegruszAdam Negrusz, University of Illinois

Adam Negrusz, Ph.D., F-ABFT, is a Laboratory Director at the United States Drug Testing Laboratory, Inc., and an Adjunct Associate Professor in the Department of Biopharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago. Dr. Negrusz received a Bachelor of Pharmacy from Nicholas Copernicus Medical University in Krakow, Poland (1981), and a Ph.D. in Pharmaceutical Sciences from the same University in Poland (1989). In 2001 he received a Habilitated Doctor degree (senior doctorate degree) from Jagiellonian University, Krakow, Poland. Adam Negrusz is a registered pharmacist (1981) and licensed toxicologist (1987) in Poland. After 8 years at the Department of Toxicology Medical University in Krakow, he joined the University of Illinois at Chicago in 1990 where he developed various procedures including the analysis of meconium, amniotic fluid and umbilical cord for cocaine. After completion of his postdoctoral training he worked for one year as a toxicologist at the Cook County Office of the Medical Examiner. In 1993 he re-joined University of Illinois and in 1995 became an Assistant Professor of Forensic Sciences and an Assistant Director of graduate studies in Forensic Sciences. In 2002 he was promoted to the rank of Associate Professor with tenure. In 2004 Dr. Adam Negrusz was appointed as a Director of the University of Illinois at Chicago Animal Forensic Toxicology Laboratory. He remained in this capacity until his departure from the University in 2014. Overall, he has over 33 years of experience in academic forensic toxicology and drug analysis which has resulted in the publication of nearly 60 articles, few book chapters, nearly 70 abstracts presented at scientific meetings, over 30 professional analytical chemistry reports for sponsors and many standard operating procedures. He is a Fellow (Toxicology Section) of the American Academy of Forensic Sciences where he served for one year as a Section Chair, a member of the Society of Forensic Toxicologists (SOFT) where he served as a member of the Board of Directors for three years, The International Association of Forensic Toxicologists (TIAFT), the Society of Hair Testing, the Midwest Association for Toxicology and Therapeutic Drug Monitoring (MATT), and Polish Society of Toxicology.

Back to top

 

J. Conor O’KeaneJ. Conor O’Keane, Mater Misericordiae University Hospital, Royal College of Physicians of Ireland

Conor O’Keane is a Consultant Histopathologist, Mater Misericordiae University Hospital, Dublin and Associate Clinical Professor of Pathology at University College Dublin. He is a 1981 graduate of University College Dublin Medical School. He obtained his pathology training at the Mallory Institute of Pathology/Boston University School of Medicine and subsequently was appointed there on staff from 1991-1993. He was Clinical Director of the Mater Hospital from 2009 to 2014. His major interest is Quality Improvement in Medicine, particularly using Lean methodologies and is an inaugural graduate of the Diploma in Leadership and Quality in Healthcare from RCPI. He is currently the Mater Clinical Director for Quality and Patient Safety and member of the hospital’s Executive Management Committee. He also serves as a Director of Bone Bank at Cappagh National Orthopaedic Hospital. He is a Diplomat of the American Board of Pathology and is a Fellow of the Faculty of Pathology, RCPI and a Fellow of the Royal College of Physicians of Ireland (FRCPI).

Back to top

 

Ruth PadmoreRuth Padmore, University of Ottawa, The Ottawa Hospital

Dr. Ruth Padmore is a graduate of Dalhousie University (MD) and Harvard University (PhD), and is a Fellow of the Royal College of Physicians and Surgeons of Canada in Anatomical Pathology and Hematological Pathology. Dr. Padmore has interests in laboratory quality and education. Dr. Padmore is Associate Professor and Director of the Hematological Pathology Residency Training Program at University of Ottawa and is currently Chair of the IQMH Hematology Scientific Committee.

Back to top

 

Jacqueline Parai, Eastern Ontario Regional Forensic Pathology Unit

Dr. Jacqueline Parai is a board certified anatomic and forensic pathologist practicing at the Eastern Ontario Regional Forensic Pathology Unit in Ottawa, Ontario.

She completed her Forensic Pathology Fellowship at the Office of the Chief Medical Examiner for the State of Maryland and became American Board certified in Forensic Pathology in 2000. She worked as a staff Forensic Pathologist at the Provincial Forensic Pathology Unit in Toronto from 2000 to 2008. During that time she also studied epidemiology with the Department of Public Health Sciences at the University of Toronto where she completed a Masters of Science degree in 2004.

In 2008 she moved to Ottawa where she was Medical Director of the Forensic Pathology Unit from 2008 to 2013. She is an Assistant Professor in the Department of Pathology and Laboratory Medicine at the University of Ottawa.

She sat on the Canadian National Committee examining the Recognition of Forensic Pathology as a Royal College Subspecialty in Canada. Currently, she is an assessor of Forensic Pathology Practice as well as a bilingual examiner for Forensic Pathology for the Royal College of Physicians and Surgeons of Canada. She sits on the editorial board member for ‘Academic Forensic Pathology’, the official publication of the National Association of Medical Examiners.

Back to top

 

Fabienne Parente, McGill University Health Center

After obtaining a PhD in the field of cancer genetics at the University of Nice-Sophia-antipolis (France), Dr. Parente pursued her post-doctoral training at the University of California San Diego (USA). She got her medical degree at the University of Montreal in 2004 and she specialized in medical biochemistry. She has been the head of pediatric clinical chemistry at the Montreal Children’s Hospital since 2011. She got her certification in biochemical genetics by the Canadian College of Medical Geneticists in 2012 and she is involved at the ministry level in the implementation of the provincial expanded newborn screening for Inborn Error of Metabolism in Québec. She also doing research to improve the diagnosis and follow up of pediatric and adult patients with metabolic disorders.

Back to top

 

Carlos Parra-Herran, University of Ottawa and The Ottawa Hospital

Dr. Parra-Herran earned his medical degree in Universidad Nacional de Colombia, and completed his residency training at Jackson Memorial Hospital (Miami, FL United States). After completing his subspecialty training in gynecologic, obstetric and breast pathology at Harvard Medical School and University of Toronto, Dr. Parra-Herran joined the Department of Pathology at the University of Ottawa in 2013. He is an active member of the gynecologic pathology group and a consultant for community pathologists across the Ottawa and Champlain region. He was awarded with the Platform Presentation Award by the International Society of Gynecological Pathologists at the 102nd United States and Canadian Academy of Pathology meeting in 2014.

Back to top

 

Marc PoulinMarc Poulin, University of Calgary

Marc Poulin is Professor of Physiology in the Faculties of Medicine (Departments of Physiology & Pharmacology, and Clinical Neurosciences) and Kinesiology, and member of the Hotchkiss Brain Institute at the University of Calgary. He holds the Brenda Strafford Foundation Chair in Alzheimer Research. He obtained a Bachelor of Physical and Health Education (Honors) from Laurentian University (Sudbury, Ontario; 1986), an MA and PhD in Exercise Physiology from the University of Western Ontario (London, Canada; 1988 and 1993) and a DPhil in Respiratory and Cerebrovascular Human Physiology from the University of Oxford (New College; Oxford, UK; 1999). His research focuses on the mechanisms of cerebrovascular regulation and perturbations in blood gases in health and disease. His two primary research areas include i) healthy brain aging and dementia (focusing on the impact of exercise on cerebral blood flow and cognitive function), and ii) the effects of intermittent hypoxia in health (using experimental human models), in workers who work at high altitude, and in the pathogenesis of obstructive sleep apnea. Dr. Poulin is leading a graduate training specialization program in Mountain Medicine and High Altitude Physiology at the University of Calgary. Since 2010, he has been interacting with Canadian mining companies to better understand the challenges imposed on miners who work at high altitude. He currently serves on the scientific advisory board of the International Hypoxia Symposia Conference series, and is Editor for the journal Experimental Physiology (Physiological Society, UK).

Back to top

 

Kathryn G. ReduckaKathryn G. Reducka, CMPA

Dr. Kathryn Reducka is Physician Risk Manager, Safe Medical Care, at the Canadian Medical Protective Association (CMPA). Dr. Reducka graduated from the University of Alberta in 1983. From 1987 to 2006, she maintained a general practice in Pembroke, Ontario which included obstetrics at the Pembroke Regional Hospital. Dr. Reducka was president of the medical staff at the Pembroke Regional Hospital for many years and sat on numerous hospital committees, including Credentials and Maternal Child Care. She also served the medical community through committees of the Ontario Medical Association, chairing the Women’s Issues Committee. In addition, she was president of Renfrew County Medical Society.

Dr. Reducka joined the CMPA as a physician risk manager in 2006.

Back to top

 

Andrew E. RosenbergAndrew E. Rosenberg, Miller School of Medicine, University of Miami

I am a surgical pathologist with expertise in the pathobiology of diseases and neoplasms of the musculoskeletal system. I began my training in Anatomic Pathology at the Massachusetts General Hospital, where I was Chief Resident, and subsequently a faculty member for a period of 30 years. During that time period I held a variety of administrative positions related to the oversight of Anatomic Pathology, the division of Bone and Soft Tissue Pathology and Quality Assurance. Concurrently, I was a faculty member of Harvard Medical School and achieved the rank of Professor. In 2011, I joined the Miller School of Medicine, University of Miami where I am Vice Chair of the Department of Pathology and Director of Bone and Soft Tissue Pathology.

My daily work focuses on the surgical pathology of the bone and soft tissue pathology – the in-house volume of tumors is very large and I also handle a significantly sized and challenging consultation practice. This experience has provided the materials for me to be able to teach pathologists, orthopedic surgeons, radiologists, and medical oncologists, and to publish over 250 articles and 50 chapters, and a book focusing on bone tumors.

Back to top

 

Catherine Ross, Hamilton Health Sciences / McMaster University

As a Pathologist, Dr. Ross provides service through the Hamilton Regional Laboratory Medicine Program. Her research interests include lymphoma diagnosis and prognosis. Dr. Ross’s clinical focus encompasses hematopathology and she is involved in diagnostics for lymphomas and leukemias. She is also the director of the flow cytometry laboratory for the LHIN4 region. She is the Chair of the Quality Assurance Program for the pathology department. Dr. Ross is also actively involved in the Undergraduate (M.D.) and Postgraduate Medical Educational Programs. She is the lab medical residency program coordinator for hematopathology and she is actively involved in undergraduate, post graduate and graduate studies teaching. Dr. Ross is currently Chair of the Canadian Association of Pathologists Hematopathology Section and the Chair of the Canadian Association of Pathologists Quality Committee.

Back to top

 

David W. Scott, British Columbia Cancer Agency

Dr. David W Scott, MBChB PhD, is a hematologist trained in Auckland, NZ. He is currently a Clinician Scientist at the BC Cancer Agency, Vancouver and an Assistant Professor at the University of British Columbia. In 2010 he moved from New Zealand to Vancouver to work with Dr. Randy Gascoyne in the Centre for Lymphoid Cancer as a post-doctoral fellow. His research interest is determinants of treatment failure in lymphoid cancers, with a focus on diffuse large B-cell lymphoma, mantle cell lymphoma and Hodgkin lymphoma. In order to translate this knowledge into clinical practice, he has developed prognsotic and predictive biomarkers using technologies applicable to routinely produced formalin-fixed paraffin-embedded tissues. In his role as a Scientist with the Leukemia Lymphoma Molecular Profiling Project (LLMPP) consortium, he contributed to the development of a new assay for determining cell-of-origin in diffuse large B-cell lymphoma, which is now being used in clinical trials for this disease.

Back to top

 

Julie Shaw, The Ottawa Hospital

Julie Shaw is a Clinical Biochemist and the Director for POCT at The Ottawa Hospital. Julie completed her PhD in Laboratory Medicine and Pathobiology at the University of Toronto. Following that Julie completed a Post-doctoral Fellowship at the University of Edinburgh in the United Kingdom where she studied the etiology of ectopic pregnancy. Julie then completed her Fellowship in Clinical Biochemistry at the University of Toronto before moving to Ottawa. Julie has recently taken on the role of Regional Discipline Lead for POCT for the Eastern Ontario Regional Laboratories Association (EORLA). In addition to her interest in POCT, Julie is interested in improving the quality of laboratory testing in the developing World. Dr. Shaw recently completed a pilot project aimed at standardizing creatinine measurements in Guyana.

Back to top

 

Victor A. TronVictor A. Tron, St. Michael’s Hospital, University of Toronto

Dr. Tron is Chief/Medical Director of Laboratory Medicine at St. Michael’s Hospital in Toronto; and Professor of Laboratory Medicine and Pathobiology at the University of Toronto. A graduate of Medicine from the University of Alberta in 1982, Dr. Tron completed his Anatomical Pathology specialty training at the University of British Columbia. He was then a Medical Research Council fellow at McMaster University and Dermatopathology fellow at the Massachusetts General Hospital under the directorship of Dr. Martin Mihm. He has a subspecialty practice focused in Dermatopathology. In the research realm, Dr. Tron has a record of national funding supporting study of molecular mechanisms of skin cancer. In June of 2015, Dr. Tron will become the next President of the Canadian Association of Pathologists–Association canadienne des pathologistes.

Back to top

 

Aaron WheelerAaron Wheeler, University of Toronto

Aaron Wheeler completed his PhD in Chemistry at Stanford University in 2003. After a two-year NIH postdoctoral fellowship at UCLA, Wheeler joined the faculty at the University of Toronto, where he is the Canada Research Chair in Bioanalytical Chemistry. Learn about the Wheeler group online at http://microfluidics.utoronto.ca/ or on twitter at @Wheeler_Lab.

Back to top

 

Michel WhiteMichel White, Montreal Heart Institute

Dr. Michel White is a Professor of Medicine at Université de Montréal and Director of the Research Program in Heart Failure at the Montreal Heart Institute. He is also the holder of the Carolyn and Richard Renaud Research Chair in Heart Failure. Dr White is also a Fellow of the American College of Cardiology and the European Society of Cardiology.

Dr White has published more than 350 papers and abstracts. He research interests involve the understanding of biomarkers related to disease progression and outcome in patients with heart failure. He also investigates the mechanisms related to the medical complications and the disorders of vascular biology in patients following cardiac transplantation. Dr White’s research interests also involve the understanding of exercise physiology applied to the high risk population such as the population with heart failure. More recently he has initiated some research projects associated with extreme physical challenges such as the Ironman.

Dr. White also played a pivotal role in some humanitarian and some extreme physical adventures. In June of 2003, for the first time in the history of organ transplant recipients, he reached the summit of Mont Blanc, along with Sylvain Bédard, a heart transplant recipient. In 2005, he initiated the expedition “Bolivia 6000”, bringing along 2 transplant recipients above 6500 meters. Together, they reached the 6 000 meters mark, a first in the history of transplant patients. In April of 2010, Dr. White reached the North Pole accompanied by Dave Shippam, a heart transplant recipient from Thunder Bay, Ontario. In December of 2012, he joined the “test your limit” expedition and reached the South Pole accompanied with Dale Shippam.

Back to top